Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Eye-Stepping training shows promise for MS balance

NCT ID NCT07233044

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an eight-week visually-guided gait training program in 40 people with multiple sclerosis. The training combined eye movement exercises with precision walking and obstacle avoidance to improve balance and mobility. Researchers measured balance, walking ability, and fall risk before and after the program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
visually-guided gait training (a type of physical therapy)
What this could lead to
If effective, this training program could offer a simple, non-drug way to improve balance and reduce falls in people with multiple sclerosis.
What could go wrong
This is a small, completed study (40 people) without a control group receiving standard care, so results may not be widely applicable. The training requires good vision and mobility, limiting who can benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Nov 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Clinically definite MS (relapsing and remitting) patients who are stable for at least three months. * Expanded Disability Status Scale (EDSS) score of ≤ 4 (fully ambulatory, self-sufficient, and able to stand and walk without any aid or orthosis at least 500 meters) to minimize the impact of motor weakness interfering with their ability to perform the task. * Normal or corrected to normal vision, wearing eyeglasses. * The age will range from 20 - 45 years. * All patients with MS were required to report subjective perceived imbalance or history of falls (in the last year) Exclusion Criteria: * Patients with any other neurological deficits or orthopedics abnormalities. * Patients with secondary musculoskeletal complications such as fractures, contractures, or deformities. * Patients with vision problems that impaired walking ability. * Patients with severe cognitive impairment or psychological disorders impaired the ability to follow the procedures of the study. * Patients with cardiovascular and respiratory diseases. * Patients with serious unstable medical condition or Patients had an acute exacerbation of MS within last month. * Pregnant women.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Multiple sclerosis

Contacts and locations

Locations

  • Kafrelsheikh University Hospital

    Kafr ash Shaykh, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.